Skip to content

Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02762890
Enrollment
56
Registered
2016-05-05
Start date
2016-10-06
Completion date
2017-02-27
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Brief summary

The purpose of this study is to investigate and compare the postoperative quality of recovery between the deep neuromuscular blockade and moderate neuromuscular blockade during robotic gastrectomy.

Interventions

neuromuscular blockade will be performed using a continuous infusion of rocuronium. Post-tetanic count 1-2 will be maintained during surgery. After the end of surgery, sugammadex of 4 mg/kg will be administered to reverse neuromuscular blockade.

neuromuscular blockade will be performed using a continuous infusion of rocuronium. Train-of-four 1-2 will be maintained during surgery. After the end of surgery, sugammadex of 2 mg/kg will be administered to reverse neuromuscular blockade.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adult patients aged 19-80 years who are scheduled for robotic gastrectomy

Exclusion criteria

* Neuromuscular disease * History of malignant hyperthermia * Significant renal or hepatic dysfunction * Allergy to sugammadex or rocuronium

Design outcomes

Primary

MeasureTime frameDescription
Postoperative quality of recoverywithin 48 hours after the end of surgery.The postoperative quality of recovery will be evaluated at 24 and 48 hours after the end of surgery by the investigator who are blinded to the group assignments.

Secondary

MeasureTime frameDescription
Surgical conditionwithin 48 hours after the end of surgerySurgical condition will be evaluated after the end of surgery by the investigator who are blinded to the group assignments.
shoulder painwithin 48 hours after the end of surgeryshoulder pain will be evaluated after the end of surgery by the investigator who are blinded to the group assignments.
abdominal painwithin 48 hours after the end of surgeryabdominal pain will be evaluated after the end of surgery by the investigator who are blinded to the group assignments.
nausea and vomitingwithin 48 hours after the end of surgerynausea and vomiting will be evaluated after the end of surgery by the investigator who are blinded to the group assignments.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026